Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to understand whether concurrent treatment for
cigarettes and e-cigarettes in which an individual quits both products at the same time
(QUIT-C) or sequential treatment in which an individual quits cigarettes first followed by
e-cigarettes is more effective for quitting both products. The study will also compare the
effect of treatment on health-related biomarkers. All participants will receive varenicline,
a medication used to treat tobacco use dependence, counseling, and cessation resources (i.e.,
links to text-based support, self-change booklet). Varenicline helps to reduce cravings for
tobacco use and decreases the pleasurable effects of cigarettes and other tobacco products.